Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML

被引：0
作者：
Mannelli, Francesco [1 ,2 ,3 ]
Piccini, Matteo [2 ]
Frigeni, Marco [4 ]
Gianfaldoni, Giacomo [2 ]
Bencini, Sara [5 ]
Salmoiraghi, Silvia [4 ]
Scappini, Barbara [2 ]
Peruzzi, Benedetta [5 ]
Caporale, Roberto [5 ]
Ciolli, Gaia [1 ,2 ]
Crupi, Francesca [1 ,2 ,3 ]
Fasano, Laura [1 ,2 ]
Quinti, Elisa [1 ,2 ]
Pasquini, Andrea [1 ,2 ]
Caroprese, Jessica [1 ,2 ,3 ]
Vanderwert, Fiorenza [2 ,3 ]
Rotunno, Giada [2 ,3 ]
Pancani, Fabiana [2 ,3 ]
Signori, Leonardo [1 ,2 ,3 ]
Tarantino, Danilo [2 ,3 ]
Maccari, Chiara [2 ,3 ]
Annunziato, Francesco [1 ,5 ]
Spinelli, Orietta [4 ]
Guglielmelli, Paola [1 ,2 ,3 ]
Rambaldi, Alessandro [4 ,6 ]
Vannucchi, Alessandro M. [1 ,2 ,3 ]
机构：
[1] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy
[2] Univ Firenze, SOD Ematol, AOU Careggi, Florence, Italy
[3] Ctr Ric & Innovaz Malattie Mieloproliferat CRIMM, AOU Careggi, Florence, Italy
[4] Azienda Socio Sanit Territoriale ASST Osped Papa G, Bergamo, Italy
[5] Ctr Diagnost Citofluorimetria & Immunoterapia, AOU Careggi, Florence, Italy
[6] Univ Milan, Dept Oncol & Hematol, Milan, Italy
来源：
BLOOD CANCER JOURNAL | 2025年 / 15卷 / 01期
关键词：
ACUTE MYELOID-LEUKEMIA; GATA2; MUTATIONS;
D O I：
10.1038/s41408-025-01224-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 18 条
  • [11] Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine
    Sebert, Marie
    Komrokji, Rami S.
    Sekeres, Mikkael A.
    Prebet, Thomas
    Cluzeau, Thomas
    Santini, Valeria
    Gyan, Emmanuel
    Sanna, Alessandro
    Ali, Najla Hai
    Hobson, Sean
    Eclache, Virginie
    List, Alan
    Fenaux, Pierre
    Ades, Lionel
    LEUKEMIA RESEARCH, 2017, 63 : 72 - 77
  • [12] Influence of genetic co-mutation on chemotherapeutic outcome in NPM1-mutated and FLT3-ITD wild-type AML patients
    Wu, Quan
    Zhang, Yujiao
    Yuan, Baoyi
    Huang, Yun
    Jiang, Ling
    Liu, Fang
    Yan, Ping
    Cheng, Jiaying
    Long, Zhiquan
    Jiang, Xuejie
    CANCER MEDICINE, 2024, 13 (15):
  • [13] Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia
    Peterlin, Pierre
    Renneville, Aline
    Ben Abdelali, Raouf
    Nibourel, Olivier
    Thomas, Xavier
    Pautas, Cecile
    de Botton, Stephane
    Raffoux, Emmanuel
    Cayuela, Jean-Michel
    Boissel, Nicolas
    Terre, Christine
    Celli-Lebras, Karine
    Castaigne, Sylvie
    Preudhomme, Claude
    Gardin, Claude
    Dombret, Herve
    HAEMATOLOGICA, 2015, 100 (05) : e196 - e199
  • [14] Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
    Yu, Guopan
    Zhang, Yu
    Yu, Sijian
    Yin, Zhao
    Weng, Guangyang
    Xu, Na
    Du, Xin
    Lin, Dongjun
    Xiao, Jie
    Sun, Zhiqiang
    Zhang, Hongyu
    Liang, Xinquan
    Guo, Ziwen
    Zhao, Weihua
    Dai, Min
    Fan, Zhiping
    Xuan, Li
    Liu, Hui
    Xu, Dan
    Ye, Jieyu
    Jiang, Xuejie
    Shi, Pengcheng
    Jin, Hua
    Liu, Qifa
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 87 - 97
  • [15] Impact of NPM1 mutation subtypes on treatment outcome in AML: The Lyon-University Hospital experience
    Heiblig, Mael
    Sujobert, Pierre
    Hayette, Sandrine
    Balsat, Marie
    Elhamri, Mohamed
    Salles, Gilles
    Thomas, Xavier
    LEUKEMIA RESEARCH, 2019, 76 : 29 - 32
  • [16] Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting
    Nanni, Jacopo
    Azzali, Irene
    Papayannidis, Cristina
    Mule, Antonino
    Audisio, Ernesta
    Martelli, Maria Paola
    Scappini, Barbara
    Chiusolo, Patrizia
    Cambo, Benedetta
    Candoni, Anna
    Lunghi, Monia
    Albano, Francesco
    Olivieri, Attilio
    Fracchiolla, Nicola
    Bernardi, Massimo
    Romani, Claudio
    Rigolin, Gian Matteo
    Giannini, Maria Benedetta
    Bocchia, Monica
    Todisco, Elisabetta
    Cilloni, Daniela
    Bochicchio, Maria Teresa
    Ottaviani, Emanuela
    Mattei, Agnese
    Zamagni, Federica
    Valli, Irene
    Volpi, Roberta
    Marconi, Giovanni
    Petracci, Elisabetta
    Martinelli, Giovanni
    CANCER, 2025, 131 (07)
  • [17] Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia
    Alarcon-Payer, Carolina
    Sanchez Suarez, Maria Del Mar
    Martin Roldan, Alicia
    Puerta Puerta, Jose Manuel
    Jimenez Morales, Alberto
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (10):
  • [18] DH1R132, DH2R140 and 1DH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies
    Meggendorfer, Manja
    Cappelli, Luca Vincenzo
    Walter, Wencke
    Haferlach, Claudia
    Kern, Wolfgang
    Falini, Brunangelo
    Haferlach, Torsten
    LEUKEMIA, 2018, 32 (05) : 1250 - +
12